Trial Profile
Efficacy Study of Tamsulosin and Tolterodine Treatment for Chronic Prostatitis.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 30 Mar 2013
Price :
$35
*
At a glance
- Drugs Tamsulosin (Primary) ; Tolterodine (Primary)
- Indications Prostatitis
- Focus Adverse reactions; Therapeutic Use
- 21 May 2012 Planned end date 31 Aug 2010 added as reported by Chinese Clinical Trial Register record.
- 20 Dec 2011 New trial record